SCTX Stock — Scribe Therapeutics Inc.: Cash, EV, Pipeline

Share price

$33.00

Market cap

$624.7M

Cash

$165.8M

Enterprise value

$458.9M

Balance sheet

Cash	$165.8M
Debt	$0.0M
Net cash	$165.8M
Enterprise value	$458.9M
Basic shares	2.5M shares
Fully diluted shares	25.1M shares
Fully diluted market cap	$829.8M
Cash per share	$66.32

Cash figures as of 2026-07-27. Database snapshot: 2026-09-21.

Price history

Loading SCTX daily closes…

Loading price history…

Pipeline assets

STX-1150

Stage not disclosed · Active Modality: in vivo CRISPR genetic medicine

Target PCSK9

Indications

Atherosclerotic cardiovascular disease (ASCVD) (Stage not disclosed)

Status note Lead product candidate for ASCVD. Filing excerpts do not state its phase or target gene; company describes itself as clinical-stage. Platform agreements (not asset-specific in excerpts): UC Regents exclusive license (CRISPR IP); Acuitas LNP development/option + non-exclusive license.

STX-1200

Preclinical · Active Modality: in vivo CRISPR genetic medicine

Target LPA

Partnerships CIRM: ~$12.7M preclinical development award (Apr 2026-Mar 2029 project period).

Indications

ASCVD (Preclinical)

Status note Developmental program; preclinical per CIRM funding for preclinical development.

STX-1400

Preclinical · Active Modality: in vivo CRISPR genetic medicine

Target APOC3

Partnerships CIRM: ~$13.0M preclinical development award (Apr 2026-Sep 2029 project period).

Indications

ASCVD (Preclinical)

Status note Developmental program; preclinical per CIRM funding for preclinical development.

Per-asset detail extracted from the 10-Q filed 2026-09-02. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.

No lead program on file for this company.

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT07428473	Phase 1	Recruiting	Collaborator	Monash University	—	Elevated LDL-C and High Cholesterol	—

Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 1 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 1 active trials for Monash University on ClinicalTrials.gov

No specialist-fund holders in 13F data for this company.

SCTX — Scribe Therapeutics Inc.

Balance sheet

Price history

Pipeline assets

Active clinical trials